Author

Richard Paul Meijer

University Medical Center UtrechtORCID 0000-0003-2510-7982Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:organoid / primary culture· 1

Frequent Co-Authors

Alba ZuidemaiD· 1 shared Bastiaan J. ViergeveriD· 1 shared Kyah van MegeseniD· 1 shared Levi Nijland· 1 shared Mette Marit Vosjan· 1 shared Onno KranenburgiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alba ZuidemaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintAug 29, 2025

ATR inhibitors synergize with mitomycin C to enhance cytotoxicity in patient-derived non-muscle invasive bladder cancer organoids

Alba Zuidema, Levi Nijland, Mette Marit Vosjan…·Richard Paul Meijer

This study shows that combining ATR inhibitors with mitomycin C significantly reduces viability of NMIBC organoids compared to chemotherapy or ATR inhibitors alone.

DOI 10.1101/2025.08.29.673024

humanorganoid / primary culture

𝕏 PostBluesky